Motion Syros: A Randomized Study Investigating the Efficacy of Tradipitant in Treating Motion Sickness

• Status: Recruiting
• Trial end date: 2020-09-01
• Target enrollment: 0
• Participant gender: All

Summary

A multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy of tradipitant in the treatment of motion sickness.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vanda Pharmaceuticals

Criteria

Inclusion Criteria:

• History of motion sickness

• Age 18-75

Exclusion Criteria:

• Nausea-inducing disorder other than motion sickness

• BMI>40

• History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists